nodes	percent_of_prediction	percent_of_DWPC	metapath
Crizotinib—ANKK1—alcohol dependence	0.589	1	CbGaD
Crizotinib—CYP3A5—Disulfiram—alcohol dependence	0.0312	0.353	CbGbCtD
Crizotinib—ABCB1—Naltrexone—alcohol dependence	0.0219	0.247	CbGbCtD
Crizotinib—ABCB1—Citalopram—alcohol dependence	0.0145	0.164	CbGbCtD
Crizotinib—CYP3A4—Disulfiram—alcohol dependence	0.0122	0.138	CbGbCtD
Crizotinib—CYP3A4—Citalopram—alcohol dependence	0.00867	0.0981	CbGbCtD
Crizotinib—Polyneuropathy—Disulfiram—alcohol dependence	0.00773	0.0722	CcSEcCtD
Crizotinib—Neuropathy—Disulfiram—alcohol dependence	0.00237	0.0221	CcSEcCtD
Crizotinib—Photopsia—Citalopram—alcohol dependence	0.00234	0.0218	CcSEcCtD
Crizotinib—Dizziness postural—Citalopram—alcohol dependence	0.00213	0.0199	CcSEcCtD
Crizotinib—Local swelling—Citalopram—alcohol dependence	0.00213	0.0199	CcSEcCtD
Crizotinib—Hepatic failure—Disulfiram—alcohol dependence	0.00204	0.019	CcSEcCtD
Crizotinib—Neuralgia—Acamprosate—alcohol dependence	0.00179	0.0167	CcSEcCtD
Crizotinib—Dysaesthesia—Citalopram—alcohol dependence	0.00172	0.0161	CcSEcCtD
Crizotinib—Abscess—Acamprosate—alcohol dependence	0.00157	0.0146	CcSEcCtD
Crizotinib—Disorder sight—Citalopram—alcohol dependence	0.00156	0.0146	CcSEcCtD
Crizotinib—Hepatotoxicity—Naltrexone—alcohol dependence	0.00152	0.0142	CcSEcCtD
Crizotinib—Sinus bradycardia—Citalopram—alcohol dependence	0.00152	0.0142	CcSEcCtD
Crizotinib—Lymphopenia—Citalopram—alcohol dependence	0.00145	0.0136	CcSEcCtD
Crizotinib—Gamma-glutamyltransferase increased—Naltrexone—alcohol dependence	0.00143	0.0133	CcSEcCtD
Crizotinib—Neuropathy peripheral—Disulfiram—alcohol dependence	0.00138	0.0129	CcSEcCtD
Crizotinib—Balance disorder—Citalopram—alcohol dependence	0.00136	0.0127	CcSEcCtD
Crizotinib—Hypoaesthesia—Disulfiram—alcohol dependence	0.00126	0.0118	CcSEcCtD
Crizotinib—Phosphatase alkaline increased—Acamprosate—alcohol dependence	0.00124	0.0116	CcSEcCtD
Crizotinib—Pulmonary embolism—Acamprosate—alcohol dependence	0.00124	0.0116	CcSEcCtD
Crizotinib—Pulmonary embolism—Naltrexone—alcohol dependence	0.00117	0.011	CcSEcCtD
Crizotinib—Photophobia—Acamprosate—alcohol dependence	0.00117	0.0109	CcSEcCtD
Crizotinib—Electrocardiogram QT prolonged—Citalopram—alcohol dependence	0.00116	0.0108	CcSEcCtD
Crizotinib—Haemoglobin decreased—Citalopram—alcohol dependence	0.00108	0.0101	CcSEcCtD
Crizotinib—Burning sensation—Citalopram—alcohol dependence	0.00107	0.01	CcSEcCtD
Crizotinib—Neuralgia—Citalopram—alcohol dependence	0.00107	0.01	CcSEcCtD
Crizotinib—Blood alkaline phosphatase increased—Acamprosate—alcohol dependence	0.00104	0.00967	CcSEcCtD
Crizotinib—Abscess—Citalopram—alcohol dependence	0.000941	0.00878	CcSEcCtD
Crizotinib—Gamma-glutamyltransferase increased—Citalopram—alcohol dependence	0.000905	0.00844	CcSEcCtD
Crizotinib—Diplopia—Acamprosate—alcohol dependence	0.000901	0.00841	CcSEcCtD
Crizotinib—Face oedema—Acamprosate—alcohol dependence	0.00087	0.00812	CcSEcCtD
Crizotinib—Face oedema—Naltrexone—alcohol dependence	0.000823	0.00768	CcSEcCtD
Crizotinib—Aspartate aminotransferase increased—Acamprosate—alcohol dependence	0.000811	0.00757	CcSEcCtD
Crizotinib—Paraesthesia—Disulfiram—alcohol dependence	0.000807	0.00753	CcSEcCtD
Crizotinib—Alanine aminotransferase increased—Acamprosate—alcohol dependence	0.000795	0.00742	CcSEcCtD
Crizotinib—Fatigue—Disulfiram—alcohol dependence	0.000775	0.00723	CcSEcCtD
Crizotinib—Aspartate aminotransferase increased—Naltrexone—alcohol dependence	0.000768	0.00716	CcSEcCtD
Crizotinib—Gait disturbance—Citalopram—alcohol dependence	0.000762	0.00712	CcSEcCtD
Crizotinib—Alanine aminotransferase increased—Naltrexone—alcohol dependence	0.000752	0.00702	CcSEcCtD
Crizotinib—Phosphatase alkaline increased—Citalopram—alcohol dependence	0.000744	0.00695	CcSEcCtD
Crizotinib—Pulmonary embolism—Citalopram—alcohol dependence	0.000744	0.00695	CcSEcCtD
Crizotinib—Fluid retention—Citalopram—alcohol dependence	0.000706	0.00659	CcSEcCtD
Crizotinib—Weight decreased—Acamprosate—alcohol dependence	0.000705	0.00658	CcSEcCtD
Crizotinib—Photophobia—Citalopram—alcohol dependence	0.000699	0.00652	CcSEcCtD
Crizotinib—Neuropathy—Citalopram—alcohol dependence	0.000699	0.00652	CcSEcCtD
Crizotinib—Pneumonia—Acamprosate—alcohol dependence	0.000698	0.00652	CcSEcCtD
Crizotinib—Upper respiratory tract infection—Naltrexone—alcohol dependence	0.000685	0.00639	CcSEcCtD
Crizotinib—Weight decreased—Naltrexone—alcohol dependence	0.000667	0.00622	CcSEcCtD
Crizotinib—Pneumonia—Naltrexone—alcohol dependence	0.000661	0.00617	CcSEcCtD
Crizotinib—Infestation—Naltrexone—alcohol dependence	0.000657	0.00613	CcSEcCtD
Crizotinib—Infestation NOS—Naltrexone—alcohol dependence	0.000657	0.00613	CcSEcCtD
Crizotinib—Sepsis—Citalopram—alcohol dependence	0.000646	0.00603	CcSEcCtD
Crizotinib—Asthenia—Disulfiram—alcohol dependence	0.000645	0.00602	CcSEcCtD
Crizotinib—Hepatobiliary disease—Naltrexone—alcohol dependence	0.000621	0.0058	CcSEcCtD
Crizotinib—Blood alkaline phosphatase increased—Citalopram—alcohol dependence	0.000621	0.0058	CcSEcCtD
Crizotinib—Hypoaesthesia—Acamprosate—alcohol dependence	0.00062	0.00579	CcSEcCtD
Crizotinib—Oedema peripheral—Acamprosate—alcohol dependence	0.000614	0.00573	CcSEcCtD
Crizotinib—Hepatic failure—Citalopram—alcohol dependence	0.000601	0.00561	CcSEcCtD
Crizotinib—Visual impairment—Acamprosate—alcohol dependence	0.000601	0.00561	CcSEcCtD
Crizotinib—Dizziness—Disulfiram—alcohol dependence	0.000595	0.00555	CcSEcCtD
Crizotinib—Visual disturbance—Citalopram—alcohol dependence	0.00057	0.00532	CcSEcCtD
Crizotinib—Rash—Disulfiram—alcohol dependence	0.000567	0.00529	CcSEcCtD
Crizotinib—Eye disorder—Naltrexone—alcohol dependence	0.000551	0.00514	CcSEcCtD
Crizotinib—Cardiac disorder—Naltrexone—alcohol dependence	0.000547	0.00511	CcSEcCtD
Crizotinib—Malnutrition—Acamprosate—alcohol dependence	0.000543	0.00506	CcSEcCtD
Crizotinib—Diplopia—Citalopram—alcohol dependence	0.00054	0.00504	CcSEcCtD
Crizotinib—Mediastinal disorder—Naltrexone—alcohol dependence	0.000532	0.00496	CcSEcCtD
Crizotinib—Dysgeusia—Acamprosate—alcohol dependence	0.000531	0.00496	CcSEcCtD
Crizotinib—Face oedema—Citalopram—alcohol dependence	0.000521	0.00487	CcSEcCtD
Crizotinib—Malnutrition—Naltrexone—alcohol dependence	0.000513	0.00479	CcSEcCtD
Crizotinib—Dysgeusia—Naltrexone—alcohol dependence	0.000503	0.00469	CcSEcCtD
Crizotinib—Anaemia—Acamprosate—alcohol dependence	0.000502	0.00468	CcSEcCtD
Crizotinib—Hypokalaemia—Citalopram—alcohol dependence	0.000492	0.00459	CcSEcCtD
Crizotinib—Syncope—Acamprosate—alcohol dependence	0.000487	0.00454	CcSEcCtD
Crizotinib—Aspartate aminotransferase increased—Citalopram—alcohol dependence	0.000486	0.00454	CcSEcCtD
Crizotinib—Leukopenia—Acamprosate—alcohol dependence	0.000486	0.00453	CcSEcCtD
Crizotinib—Vision blurred—Naltrexone—alcohol dependence	0.000484	0.00452	CcSEcCtD
Crizotinib—Loss of consciousness—Acamprosate—alcohol dependence	0.000477	0.00445	CcSEcCtD
Crizotinib—Alanine aminotransferase increased—Citalopram—alcohol dependence	0.000476	0.00445	CcSEcCtD
Crizotinib—Muscular weakness—Citalopram—alcohol dependence	0.000476	0.00445	CcSEcCtD
Crizotinib—Syncope—Naltrexone—alcohol dependence	0.00046	0.0043	CcSEcCtD
Crizotinib—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.000459	0.00428	CcSEcCtD
Crizotinib—Loss of consciousness—Naltrexone—alcohol dependence	0.000451	0.00421	CcSEcCtD
Crizotinib—Infection—Acamprosate—alcohol dependence	0.00044	0.00411	CcSEcCtD
Crizotinib—Shock—Acamprosate—alcohol dependence	0.000436	0.00407	CcSEcCtD
Crizotinib—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.000434	0.00405	CcSEcCtD
Crizotinib—Upper respiratory tract infection—Citalopram—alcohol dependence	0.000434	0.00405	CcSEcCtD
Crizotinib—Skin disorder—Acamprosate—alcohol dependence	0.00043	0.00401	CcSEcCtD
Crizotinib—Weight decreased—Citalopram—alcohol dependence	0.000422	0.00394	CcSEcCtD
Crizotinib—Oedema—Naltrexone—alcohol dependence	0.000419	0.00391	CcSEcCtD
Crizotinib—Pneumonia—Citalopram—alcohol dependence	0.000419	0.00391	CcSEcCtD
Crizotinib—Infection—Naltrexone—alcohol dependence	0.000416	0.00388	CcSEcCtD
Crizotinib—Infestation—Citalopram—alcohol dependence	0.000416	0.00388	CcSEcCtD
Crizotinib—Infestation NOS—Citalopram—alcohol dependence	0.000416	0.00388	CcSEcCtD
Crizotinib—Shock—Naltrexone—alcohol dependence	0.000412	0.00385	CcSEcCtD
Crizotinib—Nervous system disorder—Naltrexone—alcohol dependence	0.000411	0.00383	CcSEcCtD
Crizotinib—Neuropathy peripheral—Citalopram—alcohol dependence	0.000408	0.00381	CcSEcCtD
Crizotinib—Skin disorder—Naltrexone—alcohol dependence	0.000407	0.0038	CcSEcCtD
Crizotinib—Paraesthesia—Acamprosate—alcohol dependence	0.000398	0.00371	CcSEcCtD
Crizotinib—Dyspnoea—Acamprosate—alcohol dependence	0.000395	0.00368	CcSEcCtD
Crizotinib—Hepatobiliary disease—Citalopram—alcohol dependence	0.000394	0.00367	CcSEcCtD
Crizotinib—Dyspepsia—Acamprosate—alcohol dependence	0.00039	0.00364	CcSEcCtD
Crizotinib—Decreased appetite—Acamprosate—alcohol dependence	0.000385	0.00359	CcSEcCtD
Crizotinib—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000382	0.00357	CcSEcCtD
Crizotinib—Bradycardia—Citalopram—alcohol dependence	0.00038	0.00355	CcSEcCtD
Crizotinib—Constipation—Acamprosate—alcohol dependence	0.000379	0.00353	CcSEcCtD
Crizotinib—Paraesthesia—Naltrexone—alcohol dependence	0.000376	0.00351	CcSEcCtD
Crizotinib—Dyspnoea—Naltrexone—alcohol dependence	0.000374	0.00349	CcSEcCtD
Crizotinib—Hypoaesthesia—Citalopram—alcohol dependence	0.000372	0.00347	CcSEcCtD
Crizotinib—Urinary tract disorder—Citalopram—alcohol dependence	0.000369	0.00344	CcSEcCtD
Crizotinib—Oedema peripheral—Citalopram—alcohol dependence	0.000368	0.00344	CcSEcCtD
Crizotinib—Urethral disorder—Citalopram—alcohol dependence	0.000366	0.00342	CcSEcCtD
Crizotinib—Decreased appetite—Naltrexone—alcohol dependence	0.000364	0.0034	CcSEcCtD
Crizotinib—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000362	0.00338	CcSEcCtD
Crizotinib—Fatigue—Naltrexone—alcohol dependence	0.000361	0.00337	CcSEcCtD
Crizotinib—Visual impairment—Citalopram—alcohol dependence	0.00036	0.00336	CcSEcCtD
Crizotinib—Constipation—Naltrexone—alcohol dependence	0.000358	0.00334	CcSEcCtD
Crizotinib—Body temperature increased—Acamprosate—alcohol dependence	0.00035	0.00327	CcSEcCtD
Crizotinib—Eye disorder—Citalopram—alcohol dependence	0.000349	0.00326	CcSEcCtD
Crizotinib—Cardiac disorder—Citalopram—alcohol dependence	0.000347	0.00324	CcSEcCtD
Crizotinib—Mediastinal disorder—Citalopram—alcohol dependence	0.000337	0.00314	CcSEcCtD
Crizotinib—Arrhythmia—Citalopram—alcohol dependence	0.000334	0.00312	CcSEcCtD
Crizotinib—Body temperature increased—Naltrexone—alcohol dependence	0.000331	0.00309	CcSEcCtD
Crizotinib—Malnutrition—Citalopram—alcohol dependence	0.000325	0.00304	CcSEcCtD
Crizotinib—Dysgeusia—Citalopram—alcohol dependence	0.000319	0.00297	CcSEcCtD
Crizotinib—Asthenia—Acamprosate—alcohol dependence	0.000318	0.00297	CcSEcCtD
Crizotinib—Vision blurred—Citalopram—alcohol dependence	0.000307	0.00286	CcSEcCtD
Crizotinib—Diarrhoea—Acamprosate—alcohol dependence	0.000303	0.00283	CcSEcCtD
Crizotinib—Anaemia—Citalopram—alcohol dependence	0.000301	0.00281	CcSEcCtD
Crizotinib—Asthenia—Naltrexone—alcohol dependence	0.000301	0.00281	CcSEcCtD
Crizotinib—Dizziness—Acamprosate—alcohol dependence	0.000293	0.00273	CcSEcCtD
Crizotinib—Syncope—Citalopram—alcohol dependence	0.000292	0.00272	CcSEcCtD
Crizotinib—Leukopenia—Citalopram—alcohol dependence	0.000291	0.00272	CcSEcCtD
Crizotinib—Diarrhoea—Naltrexone—alcohol dependence	0.000287	0.00268	CcSEcCtD
Crizotinib—Loss of consciousness—Citalopram—alcohol dependence	0.000286	0.00267	CcSEcCtD
Crizotinib—Vomiting—Acamprosate—alcohol dependence	0.000282	0.00263	CcSEcCtD
Crizotinib—Rash—Acamprosate—alcohol dependence	0.000279	0.00261	CcSEcCtD
Crizotinib—Dermatitis—Acamprosate—alcohol dependence	0.000279	0.0026	CcSEcCtD
Crizotinib—Dizziness—Naltrexone—alcohol dependence	0.000277	0.00259	CcSEcCtD
Crizotinib—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000275	0.00257	CcSEcCtD
Crizotinib—Vomiting—Naltrexone—alcohol dependence	0.000266	0.00249	CcSEcCtD
Crizotinib—Oedema—Citalopram—alcohol dependence	0.000265	0.00248	CcSEcCtD
Crizotinib—Rash—Naltrexone—alcohol dependence	0.000264	0.00247	CcSEcCtD
Crizotinib—Dermatitis—Naltrexone—alcohol dependence	0.000264	0.00246	CcSEcCtD
Crizotinib—Infection—Citalopram—alcohol dependence	0.000264	0.00246	CcSEcCtD
Crizotinib—Nausea—Acamprosate—alcohol dependence	0.000263	0.00246	CcSEcCtD
Crizotinib—Shock—Citalopram—alcohol dependence	0.000261	0.00244	CcSEcCtD
Crizotinib—Nervous system disorder—Citalopram—alcohol dependence	0.00026	0.00243	CcSEcCtD
Crizotinib—Skin disorder—Citalopram—alcohol dependence	0.000258	0.00241	CcSEcCtD
Crizotinib—Nausea—Naltrexone—alcohol dependence	0.000249	0.00232	CcSEcCtD
Crizotinib—Paraesthesia—Citalopram—alcohol dependence	0.000238	0.00222	CcSEcCtD
Crizotinib—Dyspnoea—Citalopram—alcohol dependence	0.000237	0.00221	CcSEcCtD
Crizotinib—Dyspepsia—Citalopram—alcohol dependence	0.000234	0.00218	CcSEcCtD
Crizotinib—Decreased appetite—Citalopram—alcohol dependence	0.000231	0.00215	CcSEcCtD
Crizotinib—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000229	0.00214	CcSEcCtD
Crizotinib—Fatigue—Citalopram—alcohol dependence	0.000229	0.00214	CcSEcCtD
Crizotinib—Constipation—Citalopram—alcohol dependence	0.000227	0.00212	CcSEcCtD
Crizotinib—Body temperature increased—Citalopram—alcohol dependence	0.00021	0.00196	CcSEcCtD
Crizotinib—Asthenia—Citalopram—alcohol dependence	0.00019	0.00178	CcSEcCtD
Crizotinib—Diarrhoea—Citalopram—alcohol dependence	0.000182	0.0017	CcSEcCtD
Crizotinib—Dizziness—Citalopram—alcohol dependence	0.000176	0.00164	CcSEcCtD
Crizotinib—Vomiting—Citalopram—alcohol dependence	0.000169	0.00158	CcSEcCtD
Crizotinib—Rash—Citalopram—alcohol dependence	0.000167	0.00156	CcSEcCtD
Crizotinib—Dermatitis—Citalopram—alcohol dependence	0.000167	0.00156	CcSEcCtD
Crizotinib—EPHA4—endocrine gland—alcohol dependence	0.000163	0.00118	CbGeAlD
Crizotinib—EPHB4—midbrain—alcohol dependence	0.000162	0.00117	CbGeAlD
Crizotinib—PTK2B—testis—alcohol dependence	0.000162	0.00117	CbGeAlD
Crizotinib—EPHA2—blood—alcohol dependence	0.000161	0.00117	CbGeAlD
Crizotinib—STK35—cerebellum—alcohol dependence	0.000161	0.00117	CbGeAlD
Crizotinib—RIPK2—testis—alcohol dependence	0.000161	0.00116	CbGeAlD
Crizotinib—ABL2—liver—alcohol dependence	0.000161	0.00116	CbGeAlD
Crizotinib—SRC—gonad—alcohol dependence	0.00016	0.00116	CbGeAlD
Crizotinib—MAP3K2—endocrine gland—alcohol dependence	0.00016	0.00116	CbGeAlD
Crizotinib—PTK2B—nervous system—alcohol dependence	0.000159	0.00115	CbGeAlD
Crizotinib—BMP2K—liver—alcohol dependence	0.000159	0.00115	CbGeAlD
Crizotinib—BMP2K—central nervous system—alcohol dependence	0.000159	0.00115	CbGeAlD
Crizotinib—CSF1R—cardiovascular system—alcohol dependence	0.000159	0.00115	CbGeAlD
Crizotinib—Nausea—Citalopram—alcohol dependence	0.000158	0.00147	CcSEcCtD
Crizotinib—MAP4K5—blood—alcohol dependence	0.000157	0.00114	CbGeAlD
Crizotinib—MAP3K3—blood—alcohol dependence	0.000157	0.00114	CbGeAlD
Crizotinib—TEK—blood—alcohol dependence	0.000157	0.00114	CbGeAlD
Crizotinib—FER—brain—alcohol dependence	0.000157	0.00114	CbGeAlD
Crizotinib—TYRO3—brain—alcohol dependence	0.000157	0.00114	CbGeAlD
Crizotinib—EPHA5—brain—alcohol dependence	0.000157	0.00114	CbGeAlD
Crizotinib—ALK—brain—alcohol dependence	0.000157	0.00114	CbGeAlD
Crizotinib—ABL2—cerebellum—alcohol dependence	0.000157	0.00114	CbGeAlD
Crizotinib—TBK1—endocrine gland—alcohol dependence	0.000157	0.00113	CbGeAlD
Crizotinib—PTK2—endocrine gland—alcohol dependence	0.000157	0.00113	CbGeAlD
Crizotinib—LYN—brain—alcohol dependence	0.000156	0.00113	CbGeAlD
Crizotinib—TYK2—endocrine gland—alcohol dependence	0.000156	0.00112	CbGeAlD
Crizotinib—EPHA4—testis—alcohol dependence	0.000155	0.00112	CbGeAlD
Crizotinib—TNK1—brain—alcohol dependence	0.000155	0.00112	CbGeAlD
Crizotinib—MAP3K3—midbrain—alcohol dependence	0.000155	0.00112	CbGeAlD
Crizotinib—TEK—midbrain—alcohol dependence	0.000155	0.00112	CbGeAlD
Crizotinib—MAP4K5—midbrain—alcohol dependence	0.000155	0.00112	CbGeAlD
Crizotinib—BMP2K—cerebellum—alcohol dependence	0.000155	0.00112	CbGeAlD
Crizotinib—BMPR1B—brain—alcohol dependence	0.000154	0.00111	CbGeAlD
Crizotinib—MAP4K1—brain—alcohol dependence	0.000154	0.00111	CbGeAlD
Crizotinib—MAP3K19—brain—alcohol dependence	0.000154	0.00111	CbGeAlD
Crizotinib—ABL1—brainstem—alcohol dependence	0.000154	0.00111	CbGeAlD
Crizotinib—PTK2B—liver—alcohol dependence	0.000153	0.00111	CbGeAlD
Crizotinib—PTK2B—central nervous system—alcohol dependence	0.000153	0.00111	CbGeAlD
Crizotinib—EPHA4—nervous system—alcohol dependence	0.000153	0.0011	CbGeAlD
Crizotinib—MAP3K2—testis—alcohol dependence	0.000152	0.0011	CbGeAlD
Crizotinib—YES1—digestive system—alcohol dependence	0.000152	0.0011	CbGeAlD
Crizotinib—RIPK2—liver—alcohol dependence	0.000152	0.0011	CbGeAlD
Crizotinib—STK10—digestive system—alcohol dependence	0.000151	0.00109	CbGeAlD
Crizotinib—TNK2—brain—alcohol dependence	0.000151	0.00109	CbGeAlD
Crizotinib—IGF1R—brain—alcohol dependence	0.000151	0.00109	CbGeAlD
Crizotinib—RPS6KB1—endocrine gland—alcohol dependence	0.000151	0.00109	CbGeAlD
Crizotinib—TAOK3—digestive system—alcohol dependence	0.00015	0.00109	CbGeAlD
Crizotinib—EPHB6—blood—alcohol dependence	0.00015	0.00109	CbGeAlD
Crizotinib—PTK2B—cerebellum—alcohol dependence	0.00015	0.00108	CbGeAlD
Crizotinib—FGR—endocrine gland—alcohol dependence	0.00015	0.00108	CbGeAlD
Crizotinib—MAP3K2—nervous system—alcohol dependence	0.00015	0.00108	CbGeAlD
Crizotinib—PTK2—testis—alcohol dependence	0.000149	0.00108	CbGeAlD
Crizotinib—TBK1—testis—alcohol dependence	0.000149	0.00108	CbGeAlD
Crizotinib—AXL—endocrine gland—alcohol dependence	0.000149	0.00108	CbGeAlD
Crizotinib—MAP4K2—brain—alcohol dependence	0.000149	0.00108	CbGeAlD
Crizotinib—RIPK2—cerebellum—alcohol dependence	0.000149	0.00107	CbGeAlD
Crizotinib—EPHB6—midbrain—alcohol dependence	0.000148	0.00107	CbGeAlD
Crizotinib—TYK2—testis—alcohol dependence	0.000148	0.00107	CbGeAlD
Crizotinib—EPHA4—central nervous system—alcohol dependence	0.000147	0.00106	CbGeAlD
Crizotinib—TIE1—brain—alcohol dependence	0.000147	0.00106	CbGeAlD
Crizotinib—STK3—brain—alcohol dependence	0.000147	0.00106	CbGeAlD
Crizotinib—SRC—digestive system—alcohol dependence	0.000147	0.00106	CbGeAlD
Crizotinib—TBK1—nervous system—alcohol dependence	0.000147	0.00106	CbGeAlD
Crizotinib—PTK2—nervous system—alcohol dependence	0.000147	0.00106	CbGeAlD
Crizotinib—IRAK1—testis—alcohol dependence	0.000146	0.00106	CbGeAlD
Crizotinib—TYK2—nervous system—alcohol dependence	0.000146	0.00105	CbGeAlD
Crizotinib—YES1—blood—alcohol dependence	0.000145	0.00105	CbGeAlD
Crizotinib—MAP3K2—liver—alcohol dependence	0.000144	0.00104	CbGeAlD
Crizotinib—MAP3K2—central nervous system—alcohol dependence	0.000144	0.00104	CbGeAlD
Crizotinib—CSF1R—gonad—alcohol dependence	0.000144	0.00104	CbGeAlD
Crizotinib—STK10—blood—alcohol dependence	0.000144	0.00104	CbGeAlD
Crizotinib—RPS6KB1—testis—alcohol dependence	0.000144	0.00104	CbGeAlD
Crizotinib—EPHA4—cerebellum—alcohol dependence	0.000144	0.00104	CbGeAlD
Crizotinib—YES1—midbrain—alcohol dependence	0.000143	0.00104	CbGeAlD
Crizotinib—TAOK3—blood—alcohol dependence	0.000143	0.00104	CbGeAlD
Crizotinib—AURKA—brain—alcohol dependence	0.000143	0.00103	CbGeAlD
Crizotinib—FGR—testis—alcohol dependence	0.000143	0.00103	CbGeAlD
Crizotinib—LCK—testis—alcohol dependence	0.000143	0.00103	CbGeAlD
Crizotinib—EPHB4—endocrine gland—alcohol dependence	0.000143	0.00103	CbGeAlD
Crizotinib—AXL—testis—alcohol dependence	0.000142	0.00103	CbGeAlD
Crizotinib—TESK1—brain—alcohol dependence	0.000142	0.00103	CbGeAlD
Crizotinib—TAOK3—midbrain—alcohol dependence	0.000142	0.00102	CbGeAlD
Crizotinib—JAK2—endocrine gland—alcohol dependence	0.000142	0.00102	CbGeAlD
Crizotinib—PTK2—liver—alcohol dependence	0.000141	0.00102	CbGeAlD
Crizotinib—TBK1—liver—alcohol dependence	0.000141	0.00102	CbGeAlD
Crizotinib—TBK1—central nervous system—alcohol dependence	0.000141	0.00102	CbGeAlD
Crizotinib—PTK2—central nervous system—alcohol dependence	0.000141	0.00102	CbGeAlD
Crizotinib—RPS6KB1—nervous system—alcohol dependence	0.000141	0.00102	CbGeAlD
Crizotinib—MAP3K2—cerebellum—alcohol dependence	0.000141	0.00102	CbGeAlD
Crizotinib—TYK2—liver—alcohol dependence	0.00014	0.00101	CbGeAlD
Crizotinib—TYK2—central nervous system—alcohol dependence	0.00014	0.00101	CbGeAlD
Crizotinib—FGR—nervous system—alcohol dependence	0.00014	0.00101	CbGeAlD
Crizotinib—EPHA2—endocrine gland—alcohol dependence	0.00014	0.00101	CbGeAlD
Crizotinib—SRC—blood—alcohol dependence	0.00014	0.00101	CbGeAlD
Crizotinib—AXL—nervous system—alcohol dependence	0.00014	0.00101	CbGeAlD
Crizotinib—IRAK1—liver—alcohol dependence	0.000138	0.001	CbGeAlD
Crizotinib—MERTK—brain—alcohol dependence	0.000138	0.000998	CbGeAlD
Crizotinib—PTK2—cerebellum—alcohol dependence	0.000138	0.000997	CbGeAlD
Crizotinib—TBK1—cerebellum—alcohol dependence	0.000138	0.000997	CbGeAlD
Crizotinib—ABL1—adrenal cortex—alcohol dependence	0.000137	0.000993	CbGeAlD
Crizotinib—TYK2—cerebellum—alcohol dependence	0.000137	0.000991	CbGeAlD
Crizotinib—SLK—testis—alcohol dependence	0.000137	0.00099	CbGeAlD
Crizotinib—TEK—endocrine gland—alcohol dependence	0.000136	0.000986	CbGeAlD
Crizotinib—MAP3K3—endocrine gland—alcohol dependence	0.000136	0.000986	CbGeAlD
Crizotinib—MAP4K5—endocrine gland—alcohol dependence	0.000136	0.000986	CbGeAlD
Crizotinib—EPHB4—testis—alcohol dependence	0.000136	0.000983	CbGeAlD
Crizotinib—RPS6KB1—liver—alcohol dependence	0.000136	0.000982	CbGeAlD
Crizotinib—RPS6KB1—central nervous system—alcohol dependence	0.000136	0.000982	CbGeAlD
Crizotinib—IRAK1—cerebellum—alcohol dependence	0.000135	0.000978	CbGeAlD
Crizotinib—LIMK2—brain—alcohol dependence	0.000135	0.000976	CbGeAlD
Crizotinib—LCK—liver—alcohol dependence	0.000135	0.000976	CbGeAlD
Crizotinib—FGR—liver—alcohol dependence	0.000135	0.000976	CbGeAlD
Crizotinib—JAK2—testis—alcohol dependence	0.000135	0.000976	CbGeAlD
Crizotinib—FGR—central nervous system—alcohol dependence	0.000135	0.000976	CbGeAlD
Crizotinib—NUAK2—brain—alcohol dependence	0.000135	0.000973	CbGeAlD
Crizotinib—AXL—liver—alcohol dependence	0.000134	0.000972	CbGeAlD
Crizotinib—AXL—central nervous system—alcohol dependence	0.000134	0.000972	CbGeAlD
Crizotinib—MAP3K12—brain—alcohol dependence	0.000134	0.000966	CbGeAlD
Crizotinib—ACVR1—brain—alcohol dependence	0.000134	0.000966	CbGeAlD
Crizotinib—EPHA2—testis—alcohol dependence	0.000133	0.000964	CbGeAlD
Crizotinib—RPS6KB1—cerebellum—alcohol dependence	0.000133	0.000959	CbGeAlD
Crizotinib—JAK2—nervous system—alcohol dependence	0.000132	0.000958	CbGeAlD
Crizotinib—CSF1R—digestive system—alcohol dependence	0.000132	0.000952	CbGeAlD
Crizotinib—AXL—cerebellum—alcohol dependence	0.000131	0.00095	CbGeAlD
Crizotinib—STK35—brain—alcohol dependence	0.000131	0.000946	CbGeAlD
Crizotinib—EPHA2—nervous system—alcohol dependence	0.000131	0.000946	CbGeAlD
Crizotinib—MAP3K3—testis—alcohol dependence	0.00013	0.000941	CbGeAlD
Crizotinib—TEK—testis—alcohol dependence	0.00013	0.000941	CbGeAlD
Crizotinib—MAP4K5—testis—alcohol dependence	0.00013	0.000941	CbGeAlD
Crizotinib—SLK—liver—alcohol dependence	0.000129	0.000936	CbGeAlD
Crizotinib—EPHB4—liver—alcohol dependence	0.000128	0.000929	CbGeAlD
Crizotinib—MAP3K3—nervous system—alcohol dependence	0.000128	0.000923	CbGeAlD
Crizotinib—TEK—nervous system—alcohol dependence	0.000128	0.000923	CbGeAlD
Crizotinib—MAP4K5—nervous system—alcohol dependence	0.000128	0.000923	CbGeAlD
Crizotinib—JAK2—liver—alcohol dependence	0.000128	0.000923	CbGeAlD
Crizotinib—ABL2—brain—alcohol dependence	0.000128	0.000922	CbGeAlD
Crizotinib—JAK2—central nervous system—alcohol dependence	0.000128	0.000922	CbGeAlD
Crizotinib—SLK—cerebellum—alcohol dependence	0.000126	0.000914	CbGeAlD
Crizotinib—EPHA2—liver—alcohol dependence	0.000126	0.000912	CbGeAlD
Crizotinib—EPHA2—central nervous system—alcohol dependence	0.000126	0.000911	CbGeAlD
Crizotinib—BMP2K—brain—alcohol dependence	0.000126	0.000911	CbGeAlD
Crizotinib—YES1—endocrine gland—alcohol dependence	0.000126	0.000911	CbGeAlD
Crizotinib—EPHB4—cerebellum—alcohol dependence	0.000126	0.000908	CbGeAlD
Crizotinib—CSF1R—blood—alcohol dependence	0.000125	0.000907	CbGeAlD
Crizotinib—ABL1—cardiovascular system—alcohol dependence	0.000125	0.000907	CbGeAlD
Crizotinib—STK10—endocrine gland—alcohol dependence	0.000125	0.000903	CbGeAlD
Crizotinib—JAK2—cerebellum—alcohol dependence	0.000125	0.000901	CbGeAlD
Crizotinib—TAOK3—endocrine gland—alcohol dependence	0.000124	0.000899	CbGeAlD
Crizotinib—EPHB6—testis—alcohol dependence	0.000124	0.000899	CbGeAlD
Crizotinib—CSF1R—midbrain—alcohol dependence	0.000124	0.000896	CbGeAlD
Crizotinib—MAP3K3—liver—alcohol dependence	0.000123	0.000889	CbGeAlD
Crizotinib—MAP4K5—liver—alcohol dependence	0.000123	0.000889	CbGeAlD
Crizotinib—TEK—liver—alcohol dependence	0.000123	0.000889	CbGeAlD
Crizotinib—MAP3K3—central nervous system—alcohol dependence	0.000123	0.000889	CbGeAlD
Crizotinib—TEK—central nervous system—alcohol dependence	0.000123	0.000889	CbGeAlD
Crizotinib—MAP4K5—central nervous system—alcohol dependence	0.000123	0.000889	CbGeAlD
Crizotinib—EPHB6—nervous system—alcohol dependence	0.000122	0.000882	CbGeAlD
Crizotinib—ABL1—pancreas—alcohol dependence	0.000122	0.000881	CbGeAlD
Crizotinib—PTK2B—brain—alcohol dependence	0.000122	0.00088	CbGeAlD
Crizotinib—SRC—endocrine gland—alcohol dependence	0.000121	0.000876	CbGeAlD
Crizotinib—RIPK2—brain—alcohol dependence	0.000121	0.000873	CbGeAlD
Crizotinib—TEK—cerebellum—alcohol dependence	0.00012	0.000869	CbGeAlD
Crizotinib—MAP3K3—cerebellum—alcohol dependence	0.00012	0.000869	CbGeAlD
Crizotinib—MAP4K5—cerebellum—alcohol dependence	0.00012	0.000869	CbGeAlD
Crizotinib—YES1—testis—alcohol dependence	0.00012	0.000869	CbGeAlD
Crizotinib—STK10—testis—alcohol dependence	0.000119	0.000861	CbGeAlD
Crizotinib—TAOK3—testis—alcohol dependence	0.000119	0.000858	CbGeAlD
Crizotinib—YES1—nervous system—alcohol dependence	0.000118	0.000853	CbGeAlD
Crizotinib—EPHB6—central nervous system—alcohol dependence	0.000117	0.000849	CbGeAlD
Crizotinib—STK10—nervous system—alcohol dependence	0.000117	0.000845	CbGeAlD
Crizotinib—EPHA4—brain—alcohol dependence	0.000117	0.000844	CbGeAlD
Crizotinib—TAOK3—nervous system—alcohol dependence	0.000116	0.000842	CbGeAlD
Crizotinib—SRC—testis—alcohol dependence	0.000116	0.000836	CbGeAlD
Crizotinib—EPHB6—cerebellum—alcohol dependence	0.000115	0.00083	CbGeAlD
Crizotinib—MAP3K2—brain—alcohol dependence	0.000114	0.000827	CbGeAlD
Crizotinib—ABL1—gonad—alcohol dependence	0.000114	0.000823	CbGeAlD
Crizotinib—YES1—liver—alcohol dependence	0.000114	0.000821	CbGeAlD
Crizotinib—YES1—central nervous system—alcohol dependence	0.000114	0.000821	CbGeAlD
Crizotinib—SRC—nervous system—alcohol dependence	0.000113	0.00082	CbGeAlD
Crizotinib—STK10—liver—alcohol dependence	0.000113	0.000814	CbGeAlD
Crizotinib—STK10—central nervous system—alcohol dependence	0.000112	0.000813	CbGeAlD
Crizotinib—TAOK3—liver—alcohol dependence	0.000112	0.000811	CbGeAlD
Crizotinib—TAOK3—central nervous system—alcohol dependence	0.000112	0.00081	CbGeAlD
Crizotinib—TBK1—brain—alcohol dependence	0.000112	0.00081	CbGeAlD
Crizotinib—PTK2—brain—alcohol dependence	0.000112	0.00081	CbGeAlD
Crizotinib—TYK2—brain—alcohol dependence	0.000111	0.000805	CbGeAlD
Crizotinib—YES1—cerebellum—alcohol dependence	0.000111	0.000802	CbGeAlD
Crizotinib—STK10—cerebellum—alcohol dependence	0.00011	0.000795	CbGeAlD
Crizotinib—IRAK1—brain—alcohol dependence	0.00011	0.000794	CbGeAlD
Crizotinib—TAOK3—cerebellum—alcohol dependence	0.00011	0.000792	CbGeAlD
Crizotinib—SRC—liver—alcohol dependence	0.000109	0.00079	CbGeAlD
Crizotinib—SRC—central nervous system—alcohol dependence	0.000109	0.00079	CbGeAlD
Crizotinib—CSF1R—endocrine gland—alcohol dependence	0.000109	0.000787	CbGeAlD
Crizotinib—RPS6KB1—brain—alcohol dependence	0.000108	0.000779	CbGeAlD
Crizotinib—FGR—brain—alcohol dependence	0.000107	0.000775	CbGeAlD
Crizotinib—SRC—cerebellum—alcohol dependence	0.000107	0.000772	CbGeAlD
Crizotinib—AXL—brain—alcohol dependence	0.000107	0.000771	CbGeAlD
Crizotinib—ABL1—digestive system—alcohol dependence	0.000104	0.000753	CbGeAlD
Crizotinib—CSF1R—testis—alcohol dependence	0.000104	0.00075	CbGeAlD
Crizotinib—SLK—brain—alcohol dependence	0.000103	0.000743	CbGeAlD
Crizotinib—EPHB4—brain—alcohol dependence	0.000102	0.000737	CbGeAlD
Crizotinib—CSF1R—nervous system—alcohol dependence	0.000102	0.000736	CbGeAlD
Crizotinib—JAK2—brain—alcohol dependence	0.000101	0.000732	CbGeAlD
Crizotinib—EPHA2—brain—alcohol dependence	0.0001	0.000723	CbGeAlD
Crizotinib—ABL1—blood—alcohol dependence	9.91e-05	0.000717	CbGeAlD
Crizotinib—CSF1R—liver—alcohol dependence	9.81e-05	0.000709	CbGeAlD
Crizotinib—CSF1R—central nervous system—alcohol dependence	9.8e-05	0.000709	CbGeAlD
Crizotinib—ABL1—midbrain—alcohol dependence	9.79e-05	0.000708	CbGeAlD
Crizotinib—MAP3K3—brain—alcohol dependence	9.76e-05	0.000706	CbGeAlD
Crizotinib—MAP4K5—brain—alcohol dependence	9.76e-05	0.000706	CbGeAlD
Crizotinib—TEK—brain—alcohol dependence	9.76e-05	0.000706	CbGeAlD
Crizotinib—CSF1R—cerebellum—alcohol dependence	9.58e-05	0.000693	CbGeAlD
Crizotinib—EPHB6—brain—alcohol dependence	9.32e-05	0.000674	CbGeAlD
Crizotinib—YES1—brain—alcohol dependence	9.01e-05	0.000652	CbGeAlD
Crizotinib—STK10—brain—alcohol dependence	8.93e-05	0.000646	CbGeAlD
Crizotinib—TAOK3—brain—alcohol dependence	8.9e-05	0.000643	CbGeAlD
Crizotinib—SRC—brain—alcohol dependence	8.67e-05	0.000627	CbGeAlD
Crizotinib—ABL1—endocrine gland—alcohol dependence	8.6e-05	0.000622	CbGeAlD
Crizotinib—ABL1—testis—alcohol dependence	8.2e-05	0.000593	CbGeAlD
Crizotinib—ABL1—nervous system—alcohol dependence	8.05e-05	0.000582	CbGeAlD
Crizotinib—CSF1R—brain—alcohol dependence	7.78e-05	0.000563	CbGeAlD
Crizotinib—ABL1—liver—alcohol dependence	7.75e-05	0.000561	CbGeAlD
Crizotinib—ABL1—central nervous system—alcohol dependence	7.75e-05	0.00056	CbGeAlD
Crizotinib—ABL1—cerebellum—alcohol dependence	7.57e-05	0.000548	CbGeAlD
Crizotinib—CYP3A5—pancreas—alcohol dependence	7.13e-05	0.000516	CbGeAlD
Crizotinib—ABL1—brain—alcohol dependence	6.15e-05	0.000445	CbGeAlD
Crizotinib—CYP3A5—digestive system—alcohol dependence	6.09e-05	0.000441	CbGeAlD
Crizotinib—CYP3A5—blood—alcohol dependence	5.8e-05	0.00042	CbGeAlD
Crizotinib—CYP3A5—endocrine gland—alcohol dependence	5.03e-05	0.000364	CbGeAlD
Crizotinib—ABCB1—forebrain—alcohol dependence	4.61e-05	0.000333	CbGeAlD
Crizotinib—CYP3A4—digestive system—alcohol dependence	4.57e-05	0.000331	CbGeAlD
Crizotinib—CYP3A5—liver—alcohol dependence	4.54e-05	0.000328	CbGeAlD
Crizotinib—CYP3A4—blood—alcohol dependence	4.36e-05	0.000315	CbGeAlD
Crizotinib—ABCB1—adrenal cortex—alcohol dependence	4.27e-05	0.000309	CbGeAlD
Crizotinib—ABCB1—cardiovascular system—alcohol dependence	3.9e-05	0.000282	CbGeAlD
Crizotinib—ABCB1—pancreas—alcohol dependence	3.79e-05	0.000274	CbGeAlD
Crizotinib—CYP3A4—endocrine gland—alcohol dependence	3.78e-05	0.000273	CbGeAlD
Crizotinib—ABCB1—gonad—alcohol dependence	3.54e-05	0.000256	CbGeAlD
Crizotinib—CYP3A4—nervous system—alcohol dependence	3.54e-05	0.000256	CbGeAlD
Crizotinib—CYP3A4—liver—alcohol dependence	3.41e-05	0.000246	CbGeAlD
Crizotinib—CYP3A4—central nervous system—alcohol dependence	3.4e-05	0.000246	CbGeAlD
Crizotinib—ABCB1—digestive system—alcohol dependence	3.24e-05	0.000234	CbGeAlD
Crizotinib—ABCB1—blood—alcohol dependence	3.08e-05	0.000223	CbGeAlD
Crizotinib—ABCB1—midbrain—alcohol dependence	3.04e-05	0.00022	CbGeAlD
Crizotinib—ABCB1—endocrine gland—alcohol dependence	2.67e-05	0.000193	CbGeAlD
Crizotinib—ABCB1—testis—alcohol dependence	2.55e-05	0.000184	CbGeAlD
Crizotinib—ABCB1—nervous system—alcohol dependence	2.5e-05	0.000181	CbGeAlD
Crizotinib—ABCB1—liver—alcohol dependence	2.41e-05	0.000174	CbGeAlD
Crizotinib—ABCB1—central nervous system—alcohol dependence	2.41e-05	0.000174	CbGeAlD
Crizotinib—ABCB1—cerebellum—alcohol dependence	2.36e-05	0.00017	CbGeAlD
Crizotinib—ABCB1—brain—alcohol dependence	1.91e-05	0.000138	CbGeAlD
Crizotinib—JAK3—Signaling Pathways—AVP—alcohol dependence	1.37e-05	0.000178	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—DRD2—alcohol dependence	1.37e-05	0.000177	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—HTR7—alcohol dependence	1.37e-05	0.000177	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—CNR1—alcohol dependence	1.36e-05	0.000176	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—CNR1—alcohol dependence	1.36e-05	0.000176	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—NPY—alcohol dependence	1.36e-05	0.000176	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—PDYN—alcohol dependence	1.35e-05	0.000175	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—CRHR1—alcohol dependence	1.34e-05	0.000174	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—WASF2—alcohol dependence	1.34e-05	0.000174	CbGpPWpGaD
Crizotinib—CYP3A4—Biological oxidations—MAOA—alcohol dependence	1.33e-05	0.000173	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—HTR7—alcohol dependence	1.33e-05	0.000172	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—DRD2—alcohol dependence	1.33e-05	0.000172	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—DRD2—alcohol dependence	1.33e-05	0.000172	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—HTR7—alcohol dependence	1.33e-05	0.000172	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—NPY—alcohol dependence	1.32e-05	0.000171	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—HTR1B—alcohol dependence	1.31e-05	0.00017	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—CRH—alcohol dependence	1.31e-05	0.00017	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—WASF1—alcohol dependence	1.29e-05	0.000167	CbGpPWpGaD
Crizotinib—PTK2—Developmental Biology—EP300—alcohol dependence	1.27e-05	0.000165	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—HTR1B—alcohol dependence	1.27e-05	0.000165	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—CRH—alcohol dependence	1.27e-05	0.000165	CbGpPWpGaD
Crizotinib—MAPK7—Immune System—EP300—alcohol dependence	1.27e-05	0.000164	CbGpPWpGaD
Crizotinib—LIMK1—Immune System—EP300—alcohol dependence	1.27e-05	0.000164	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—CHRM2—alcohol dependence	1.26e-05	0.000164	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—POMC—alcohol dependence	1.26e-05	0.000163	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—ADH1A—alcohol dependence	1.26e-05	0.000163	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—CRHR1—alcohol dependence	1.26e-05	0.000163	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—WASF2—alcohol dependence	1.26e-05	0.000163	CbGpPWpGaD
Crizotinib—YES1—Developmental Biology—EP300—alcohol dependence	1.26e-05	0.000162	CbGpPWpGaD
Crizotinib—PTK2—Hemostasis—EP300—alcohol dependence	1.25e-05	0.000162	CbGpPWpGaD
Crizotinib—JAK2—Disease—GOT2—alcohol dependence	1.25e-05	0.000161	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—OPRD1—alcohol dependence	1.24e-05	0.00016	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—POMC—alcohol dependence	1.23e-05	0.00016	CbGpPWpGaD
Crizotinib—JAK2—GPCR downstream signaling—AVP—alcohol dependence	1.23e-05	0.000159	CbGpPWpGaD
Crizotinib—YES1—Hemostasis—EP300—alcohol dependence	1.23e-05	0.000159	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—HTR2A—alcohol dependence	1.23e-05	0.000159	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—DRD4—alcohol dependence	1.22e-05	0.000158	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—AVP—alcohol dependence	1.22e-05	0.000158	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—EP300—alcohol dependence	1.22e-05	0.000158	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—EP300—alcohol dependence	1.22e-05	0.000158	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—DRD4—alcohol dependence	1.21e-05	0.000156	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—ADH7—alcohol dependence	1.21e-05	0.000156	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—AVP—alcohol dependence	1.21e-05	0.000156	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—WASF1—alcohol dependence	1.21e-05	0.000156	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—PDYN—alcohol dependence	1.19e-05	0.000153	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—CHRM2—alcohol dependence	1.18e-05	0.000153	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—CNR1—alcohol dependence	1.17e-05	0.000151	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—OPRM1—alcohol dependence	1.16e-05	0.00015	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—EP300—alcohol dependence	1.16e-05	0.00015	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—GGT2—alcohol dependence	1.16e-05	0.00015	CbGpPWpGaD
Crizotinib—TYK2—Developmental Biology—EP300—alcohol dependence	1.16e-05	0.00015	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—AVP—alcohol dependence	1.15e-05	0.000149	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—CNR1—alcohol dependence	1.15e-05	0.000149	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—DRD4—alcohol dependence	1.15e-05	0.000148	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—HTR2A—alcohol dependence	1.14e-05	0.000148	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—DRD2—alcohol dependence	1.14e-05	0.000148	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—HTR7—alcohol dependence	1.14e-05	0.000148	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—DRD2—alcohol dependence	1.12e-05	0.000146	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—HTR7—alcohol dependence	1.12e-05	0.000146	CbGpPWpGaD
Crizotinib—PTK2—Innate Immune System—EP300—alcohol dependence	1.12e-05	0.000145	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—AVP—alcohol dependence	1.12e-05	0.000145	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—AVP—alcohol dependence	1.12e-05	0.000145	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—DRD4—alcohol dependence	1.11e-05	0.000144	CbGpPWpGaD
Crizotinib—YES1—Innate Immune System—EP300—alcohol dependence	1.11e-05	0.000143	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—CRHR1—alcohol dependence	1.1e-05	0.000143	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—WASF2—alcohol dependence	1.1e-05	0.000143	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—OPRD1—alcohol dependence	1.09e-05	0.000142	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—CNR1—alcohol dependence	1.09e-05	0.000142	CbGpPWpGaD
Crizotinib—LCK—Disease—GOT2—alcohol dependence	1.09e-05	0.000141	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—OPRM1—alcohol dependence	1.09e-05	0.000141	CbGpPWpGaD
Crizotinib—JAK2—Disease—GOT1—alcohol dependence	1.07e-05	0.000139	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—ADH4—alcohol dependence	1.07e-05	0.000139	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—NPY—alcohol dependence	1.07e-05	0.000138	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—DRD2—alcohol dependence	1.07e-05	0.000138	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—HTR7—alcohol dependence	1.07e-05	0.000138	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—CNR1—alcohol dependence	1.06e-05	0.000137	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—EP300—alcohol dependence	1.06e-05	0.000137	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—ADH1B—alcohol dependence	1.06e-05	0.000137	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—WASF1—alcohol dependence	1.06e-05	0.000137	CbGpPWpGaD
Crizotinib—IRAK1—Innate Immune System—EP300—alcohol dependence	1.05e-05	0.000136	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—PDYN—alcohol dependence	1.05e-05	0.000136	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—CHRM2—alcohol dependence	1.04e-05	0.000134	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—HTR7—alcohol dependence	1.04e-05	0.000134	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—DRD2—alcohol dependence	1.04e-05	0.000134	CbGpPWpGaD
Crizotinib—TBK1—Immune System—EP300—alcohol dependence	1.04e-05	0.000134	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—HTR1B—alcohol dependence	1.03e-05	0.000133	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—CRH—alcohol dependence	1.03e-05	0.000133	CbGpPWpGaD
Crizotinib—JAK2—GPCR downstream signaling—HTR2A—alcohol dependence	1.02e-05	0.000133	CbGpPWpGaD
Crizotinib—TYK2—Innate Immune System—EP300—alcohol dependence	1.02e-05	0.000132	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—HTR2A—alcohol dependence	1.02e-05	0.000132	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—HTR2A—alcohol dependence	1e-05	0.00013	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—NPY—alcohol dependence	9.99e-06	0.000129	CbGpPWpGaD
Crizotinib—MAP3K3—Immune System—EP300—alcohol dependence	9.92e-06	0.000128	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—POMC—alcohol dependence	9.81e-06	0.000127	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—WASF2—alcohol dependence	9.75e-06	0.000126	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CRHR1—alcohol dependence	9.75e-06	0.000126	CbGpPWpGaD
Crizotinib—SRC—Disease—GOT2—alcohol dependence	9.65e-06	0.000125	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—HTR1B—alcohol dependence	9.64e-06	0.000125	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—CRH—alcohol dependence	9.64e-06	0.000125	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—HTR2A—alcohol dependence	9.6e-06	0.000124	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—AVP—alcohol dependence	9.6e-06	0.000124	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—OPRM1—alcohol dependence	9.51e-06	0.000123	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—AVP—alcohol dependence	9.47e-06	0.000123	CbGpPWpGaD
Crizotinib—LCK—Disease—GOT1—alcohol dependence	9.41e-06	0.000122	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ADH6—alcohol dependence	9.36e-06	0.000121	CbGpPWpGaD
Crizotinib—JAK3—Immune System—EP300—alcohol dependence	9.36e-06	0.000121	CbGpPWpGaD
Crizotinib—LYN—Developmental Biology—EP300—alcohol dependence	9.36e-06	0.000121	CbGpPWpGaD
Crizotinib—ABCB1—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	9.36e-06	0.000121	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—WASF1—alcohol dependence	9.35e-06	0.000121	CbGpPWpGaD
Crizotinib—ABL1—Developmental Biology—EP300—alcohol dependence	9.32e-06	0.000121	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—HTR2A—alcohol dependence	9.31e-06	0.000121	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—HTR2A—alcohol dependence	9.31e-06	0.00012	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—EP300—alcohol dependence	9.26e-06	0.00012	CbGpPWpGaD
Crizotinib—LYN—Hemostasis—EP300—alcohol dependence	9.18e-06	0.000119	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CHRM2—alcohol dependence	9.17e-06	0.000119	CbGpPWpGaD
Crizotinib—ABL1—Hemostasis—EP300—alcohol dependence	9.14e-06	0.000118	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—POMC—alcohol dependence	9.12e-06	0.000118	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—ADH7—alcohol dependence	9.11e-06	0.000118	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—DRD4—alcohol dependence	9e-06	0.000117	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—AVP—alcohol dependence	8.98e-06	0.000116	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—MAOB—alcohol dependence	8.77e-06	0.000113	CbGpPWpGaD
Crizotinib—JAK2—Developmental Biology—EP300—alcohol dependence	8.76e-06	0.000113	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—NPY—alcohol dependence	8.75e-06	0.000113	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—GGT2—alcohol dependence	8.73e-06	0.000113	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—AVP—alcohol dependence	8.72e-06	0.000113	CbGpPWpGaD
Crizotinib—CYP3A4—Biological oxidations—POMC—alcohol dependence	8.68e-06	0.000112	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—CNR1—alcohol dependence	8.6e-06	0.000111	CbGpPWpGaD
Crizotinib—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	8.59e-06	0.000111	CbGpPWpGaD
Crizotinib—JAK2—Hemostasis—EP300—alcohol dependence	8.59e-06	0.000111	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—HTR1B—alcohol dependence	8.44e-06	0.000109	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—CRH—alcohol dependence	8.44e-06	0.000109	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—DRD4—alcohol dependence	8.43e-06	0.000109	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—OPRM1—alcohol dependence	8.42e-06	0.000109	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—DRD2—alcohol dependence	8.39e-06	0.000109	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—HTR7—alcohol dependence	8.39e-06	0.000109	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—EP300—alcohol dependence	8.37e-06	0.000108	CbGpPWpGaD
Crizotinib—RIPK2—Immune System—EP300—alcohol dependence	8.34e-06	0.000108	CbGpPWpGaD
Crizotinib—SRC—Disease—GOT1—alcohol dependence	8.33e-06	0.000108	CbGpPWpGaD
Crizotinib—LYN—Innate Immune System—EP300—alcohol dependence	8.27e-06	0.000107	CbGpPWpGaD
Crizotinib—ABL1—Innate Immune System—EP300—alcohol dependence	8.23e-06	0.000106	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—EP300—alcohol dependence	8.22e-06	0.000106	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—EP300—alcohol dependence	8.19e-06	0.000106	CbGpPWpGaD
Crizotinib—JAK2—GPCR downstream signaling—POMC—alcohol dependence	8.19e-06	0.000106	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—POMC—alcohol dependence	8.13e-06	0.000105	CbGpPWpGaD
Crizotinib—CDK7—Disease—EP300—alcohol dependence	8.07e-06	0.000105	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—CNR1—alcohol dependence	8.05e-06	0.000104	CbGpPWpGaD
Crizotinib—BLK—Immune System—EP300—alcohol dependence	8.03e-06	0.000104	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—POMC—alcohol dependence	8.01e-06	0.000104	CbGpPWpGaD
Crizotinib—FGR—Immune System—EP300—alcohol dependence	8e-06	0.000104	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—HTR2A—alcohol dependence	7.99e-06	0.000103	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—ADH1B—alcohol dependence	7.98e-06	0.000103	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—HTR2A—alcohol dependence	7.88e-06	0.000102	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—HTR7—alcohol dependence	7.85e-06	0.000102	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—DRD2—alcohol dependence	7.85e-06	0.000102	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ADH1A—alcohol dependence	7.76e-06	0.0001	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—NPY—alcohol dependence	7.75e-06	0.0001	CbGpPWpGaD
Crizotinib—ABCB1—Transmembrane transport of small molecules—AVP—alcohol dependence	7.74e-06	0.0001	CbGpPWpGaD
Crizotinib—JAK2—Innate Immune System—EP300—alcohol dependence	7.74e-06	0.0001	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—POMC—alcohol dependence	7.67e-06	9.93e-05	CbGpPWpGaD
Crizotinib—LCK—Hemostasis—EP300—alcohol dependence	7.53e-06	9.74e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CRH—alcohol dependence	7.48e-06	9.68e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—HTR1B—alcohol dependence	7.48e-06	9.68e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—HTR2A—alcohol dependence	7.47e-06	9.67e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—ALDH2—alcohol dependence	7.45e-06	9.65e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—POMC—alcohol dependence	7.44e-06	9.63e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—POMC—alcohol dependence	7.43e-06	9.62e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—DRD4—alcohol dependence	7.38e-06	9.55e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—HTR2A—alcohol dependence	7.25e-06	9.39e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—AVP—alcohol dependence	7.06e-06	9.14e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—CNR1—alcohol dependence	7.05e-06	9.12e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—HTR7—alcohol dependence	6.88e-06	8.9e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—DRD2—alcohol dependence	6.88e-06	8.9e-05	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—EP300—alcohol dependence	6.79e-06	8.79e-05	CbGpPWpGaD
Crizotinib—LCK—Innate Immune System—EP300—alcohol dependence	6.77e-06	8.77e-05	CbGpPWpGaD
Crizotinib—SRC—Hemostasis—EP300—alcohol dependence	6.66e-06	8.62e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—MAOB—alcohol dependence	6.62e-06	8.56e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—AVP—alcohol dependence	6.61e-06	8.55e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ADH4—alcohol dependence	6.6e-06	8.54e-05	CbGpPWpGaD
Crizotinib—PTK2—Immune System—EP300—alcohol dependence	6.55e-06	8.47e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—DRD4—alcohol dependence	6.53e-06	8.46e-05	CbGpPWpGaD
Crizotinib—YES1—Immune System—EP300—alcohol dependence	6.46e-06	8.36e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—POMC—alcohol dependence	6.38e-06	8.26e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—GOT2—alcohol dependence	6.34e-06	8.2e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—POMC—alcohol dependence	6.29e-06	8.14e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CNR1—alcohol dependence	6.24e-06	8.08e-05	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—EP300—alcohol dependence	6.12e-06	7.93e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—DRD2—alcohol dependence	6.09e-06	7.88e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—HTR7—alcohol dependence	6.09e-06	7.88e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—EP300—alcohol dependence	6.05e-06	7.83e-05	CbGpPWpGaD
Crizotinib—SRC—Innate Immune System—EP300—alcohol dependence	6e-06	7.76e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—POMC—alcohol dependence	5.97e-06	7.72e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—CYP2E1—alcohol dependence	5.96e-06	7.71e-05	CbGpPWpGaD
Crizotinib—TYK2—Immune System—EP300—alcohol dependence	5.94e-06	7.69e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—HTR2A—alcohol dependence	5.88e-06	7.6e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—POMC—alcohol dependence	5.79e-06	7.5e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—AVP—alcohol dependence	5.79e-06	7.49e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—ALDH2—alcohol dependence	5.63e-06	7.28e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ADH7—alcohol dependence	5.61e-06	7.26e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—HTR2A—alcohol dependence	5.5e-06	7.12e-05	CbGpPWpGaD
Crizotinib—TYK2—Disease—EP300—alcohol dependence	5.49e-06	7.1e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—GGT1—alcohol dependence	5.47e-06	7.08e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—GOT1—alcohol dependence	5.47e-06	7.08e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—EP300—alcohol dependence	5.39e-06	6.98e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GGT2—alcohol dependence	5.38e-06	6.96e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—EP300—alcohol dependence	5.32e-06	6.88e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—AVP—alcohol dependence	5.12e-06	6.63e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—EP300—alcohol dependence	5.09e-06	6.59e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—EP300—alcohol dependence	4.93e-06	6.39e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ADH1B—alcohol dependence	4.92e-06	6.37e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—MAOA—alcohol dependence	4.9e-06	6.35e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—HTR2A—alcohol dependence	4.82e-06	6.23e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—EP300—alcohol dependence	4.81e-06	6.23e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—EP300—alcohol dependence	4.79e-06	6.2e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—GOT2—alcohol dependence	4.78e-06	6.19e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—POMC—alcohol dependence	4.69e-06	6.07e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—EP300—alcohol dependence	4.51e-06	5.83e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—CYP2E1—alcohol dependence	4.5e-06	5.82e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—POMC—alcohol dependence	4.39e-06	5.68e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—HTR2A—alcohol dependence	4.26e-06	5.52e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—EP300—alcohol dependence	4.23e-06	5.48e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—EP300—alcohol dependence	4.17e-06	5.4e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—EP300—alcohol dependence	4.16e-06	5.38e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—GGT1—alcohol dependence	4.13e-06	5.34e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—GOT1—alcohol dependence	4.13e-06	5.34e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—MAOB—alcohol dependence	4.08e-06	5.28e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—EP300—alcohol dependence	3.96e-06	5.12e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—EP300—alcohol dependence	3.95e-06	5.11e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—POMC—alcohol dependence	3.85e-06	4.98e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—EP300—alcohol dependence	3.84e-06	4.97e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—MAOA—alcohol dependence	3.7e-06	4.79e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—EP300—alcohol dependence	3.64e-06	4.72e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—EP300—alcohol dependence	3.49e-06	4.52e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ALDH2—alcohol dependence	3.47e-06	4.49e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—POMC—alcohol dependence	3.4e-06	4.41e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—EP300—alcohol dependence	3.23e-06	4.17e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—POMC—alcohol dependence	3.19e-06	4.13e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—EP300—alcohol dependence	3.11e-06	4.03e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GOT2—alcohol dependence	2.95e-06	3.81e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—EP300—alcohol dependence	2.91e-06	3.77e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CYP2E1—alcohol dependence	2.77e-06	3.59e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—EP300—alcohol dependence	2.55e-06	3.3e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GOT1—alcohol dependence	2.54e-06	3.29e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GGT1—alcohol dependence	2.54e-06	3.29e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—POMC—alcohol dependence	2.41e-06	3.12e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—MAOA—alcohol dependence	2.28e-06	2.95e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—EP300—alcohol dependence	2.26e-06	2.92e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—EP300—alcohol dependence	2.12e-06	2.74e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—EP300—alcohol dependence	1.6e-06	2.07e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—POMC—alcohol dependence	1.48e-06	1.92e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—EP300—alcohol dependence	9.85e-07	1.27e-05	CbGpPWpGaD
